232120 Sigma-AldrichCisplatin - CAS 15663-27-1 - Calbiochem
Cisplatin - CAS 15663-27-1, is a platinum coordination complex with potent anti-neoplastic activity. Induces apoptosis in cancer cells, possibly via caspase-3 activation.
More>> Cisplatin - CAS 15663-27-1, is a platinum coordination complex with potent anti-neoplastic activity. Induces apoptosis in cancer cells, possibly via caspase-3 activation. Less<<Cisplatin - CAS 15663-27-1 - Calbiochem : FDS (Fiches de données de sécurité), certificats d’analyse (CoA) et de qualité (CoQ), dossiers, brochures et autres documents disponibles.
Synonymes: CPDC, DDP, cis-Diaminedichloroplatinum
Produits recommandés
Aperçu
Replacement Information |
---|
Tableau de caractéristiques principal
CAS # | Empirical Formula |
---|---|
15663-27-1 | Pt(NH₃)₂Cl₂ |
Prix & Disponibilité
Référence | Disponibilité | Conditionnement | Qté | Prix | Quantité | |
---|---|---|---|---|---|---|
232120-50MG |
|
Flacon en verre | 50 mg |
|
— |
Product Information | |
---|---|
CAS number | 15663-27-1 |
ATP Competitive | N |
Form | Yellow solid |
Hill Formula | Pt(NH₃)₂Cl₂ |
Chemical formula | Pt(NH₃)₂Cl₂ |
Reversible | N |
Structure formula Image | |
Quality Level | MQ100 |
Applications |
---|
Biological Information | |
---|---|
Primary Target | Induces apoptosis in cancer cells |
Purity | ≥98% by HPLC |
Physicochemical Information | |
---|---|
Cell permeable | N |
Dimensions |
---|
Materials Information |
---|
Toxicological Information |
---|
Safety Information according to GHS | |
---|---|
RTECS | TP2450000 |
Product Usage Statements |
---|
Packaging Information |
---|
Transport Information |
---|
Supplemental Information |
---|
Specifications |
---|
Documentation
Cisplatin - CAS 15663-27-1 - Calbiochem FDS
Titre |
---|
Cisplatin - CAS 15663-27-1 - Calbiochem Certificats d'analyse
Titre | Numéro de lot |
---|---|
232120 |
Références bibliographiques
Aperçu de la référence bibliographique |
---|
Hall, M.D., et al. 2014. Cancer Res. In press. Duan, L., et al. 2001. J. Neurooncol. 52, 23. Mese, H., et al. 2000. Cancer Chemother. Pharmacol. 46, 241. Von Hoff, D.D., and Rozencweig, M. 1979. in Adv. Pharmacol. Chemother. 16, 279. |